| 0.5 |
1.4 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 |
1.7 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 |
1.4 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.3 |
1.2 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.3 |
1.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
0.3 |
GO:0017143 |
insecticide metabolic process(GO:0017143) |
| 0.3 |
0.3 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.2 |
2.7 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.2 |
0.8 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.2 |
0.9 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 |
0.5 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.2 |
0.6 |
GO:1903517 |
regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.2 |
1.1 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.4 |
GO:0043311 |
positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 |
0.4 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.1 |
0.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
1.8 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.1 |
0.8 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.4 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 |
2.3 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.1 |
0.3 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
0.3 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.6 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 |
0.7 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.1 |
0.8 |
GO:0071386 |
cellular response to corticosterone stimulus(GO:0071386) |
| 0.1 |
0.4 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.1 |
1.6 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
0.9 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.1 |
0.5 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.1 |
0.3 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
0.2 |
GO:0071106 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) NAD transport(GO:0043132) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 |
0.2 |
GO:0018194 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 |
0.6 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 |
0.2 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.6 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 |
2.9 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
0.2 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 |
0.2 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.1 |
0.4 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 |
0.3 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.1 |
7.2 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
0.5 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.4 |
GO:0097368 |
membrane to membrane docking(GO:0022614) establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
0.2 |
GO:0072684 |
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.1 |
0.1 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.1 |
0.2 |
GO:0007037 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.1 |
0.2 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.1 |
0.3 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.1 |
0.4 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 |
0.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.3 |
GO:0015817 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.1 |
0.2 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.1 |
1.1 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.1 |
0.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.6 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.4 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.4 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 |
0.3 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
0.3 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 |
0.6 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.1 |
0.2 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 |
0.5 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.3 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.1 |
0.3 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.3 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.1 |
0.1 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
1.0 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.2 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.2 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.1 |
0.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.2 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.0 |
0.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.1 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.0 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.2 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.0 |
0.3 |
GO:2000782 |
regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.0 |
0.3 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.3 |
GO:1903281 |
protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.0 |
0.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 |
0.1 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.0 |
0.2 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.0 |
0.3 |
GO:0009799 |
specification of symmetry(GO:0009799) determination of bilateral symmetry(GO:0009855) |
| 0.0 |
0.2 |
GO:0070895 |
transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.0 |
0.1 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 0.0 |
0.4 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.0 |
0.3 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.0 |
0.2 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.0 |
0.1 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.0 |
0.2 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.0 |
0.2 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.0 |
0.2 |
GO:1903826 |
arginine transmembrane transport(GO:1903826) |
| 0.0 |
0.6 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.0 |
0.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 |
0.2 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.3 |
GO:1901295 |
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 0.0 |
0.5 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.4 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 |
0.1 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 |
0.0 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.4 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.2 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.0 |
0.3 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.2 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.0 |
0.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.2 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.0 |
0.1 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.0 |
0.2 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.1 |
GO:1901355 |
response to rapamycin(GO:1901355) response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.0 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
0.2 |
GO:0048389 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) deltoid tuberosity development(GO:0035993) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.0 |
0.2 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.0 |
0.3 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) |
| 0.0 |
0.3 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.2 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.6 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.0 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.2 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 |
0.3 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.0 |
0.3 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.2 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.0 |
0.2 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.0 |
0.3 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.0 |
0.4 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 |
0.4 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.5 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.1 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.0 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
0.1 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.0 |
0.1 |
GO:0051598 |
meiotic recombination checkpoint(GO:0051598) |
| 0.0 |
0.1 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.0 |
0.3 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 |
0.1 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.0 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.6 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 |
0.1 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 |
0.1 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.0 |
0.3 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.0 |
0.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.9 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.1 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.2 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.1 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.0 |
0.1 |
GO:1903979 |
negative regulation of microglial cell activation(GO:1903979) |
| 0.0 |
0.1 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.5 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.1 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.1 |
GO:0060492 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.0 |
0.1 |
GO:1900368 |
pre-miRNA export from nucleus(GO:0035281) regulation of RNA interference(GO:1900368) |
| 0.0 |
0.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
0.2 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.2 |
GO:0051177 |
meiotic DNA recombinase assembly(GO:0000707) meiotic sister chromatid cohesion(GO:0051177) |
| 0.0 |
0.3 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.0 |
0.1 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.0 |
0.1 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 |
0.4 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.5 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 |
0.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.1 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 |
0.6 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 |
0.2 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.0 |
0.4 |
GO:0060211 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 |
0.0 |
GO:0072194 |
renal artery morphogenesis(GO:0061441) kidney smooth muscle tissue development(GO:0072194) |
| 0.0 |
0.2 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.1 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
0.1 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.0 |
0.1 |
GO:1901340 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.0 |
0.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.3 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.2 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.0 |
0.1 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.0 |
0.1 |
GO:0035283 |
rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.0 |
0.0 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.5 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.0 |
0.3 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.0 |
0.3 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.0 |
0.5 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.0 |
GO:0045954 |
positive regulation of leukocyte mediated cytotoxicity(GO:0001912) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 |
0.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.1 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.0 |
0.1 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.1 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 |
0.1 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.1 |
GO:0090307 |
mitotic spindle assembly(GO:0090307) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.9 |
GO:0036336 |
dendritic cell migration(GO:0036336) |
| 0.0 |
0.5 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.1 |
GO:0045080 |
positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.0 |
0.2 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.1 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.0 |
0.2 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.0 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.0 |
0.3 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.1 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.3 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 |
0.2 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.0 |
0.3 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.1 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.0 |
0.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
0.1 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.0 |
0.2 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.0 |
0.2 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 |
0.2 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.1 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.3 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.0 |
0.6 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
2.3 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.5 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.2 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.0 |
0.2 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.0 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.0 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.1 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.0 |
0.3 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.1 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.0 |
0.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.3 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.5 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.2 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.0 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.1 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.1 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.1 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) negative regulation of hair follicle development(GO:0051799) |
| 0.0 |
0.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.1 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:0061015 |
RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
| 0.0 |
0.1 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.0 |
0.2 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.1 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.0 |
0.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.3 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.3 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.0 |
0.1 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 |
0.0 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 |
0.0 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.0 |
0.0 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.0 |
0.3 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.0 |
0.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.7 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.1 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 |
0.1 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.0 |
0.2 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.0 |
0.2 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.1 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.2 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.0 |
0.1 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.0 |
0.1 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.0 |
0.0 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.0 |
0.1 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 |
0.4 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.0 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.0 |
0.0 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.8 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.1 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 |
1.3 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.0 |
0.2 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.2 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.0 |
0.9 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.1 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.2 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.0 |
0.0 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.0 |
0.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.0 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.0 |
0.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.2 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.0 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.0 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 |
0.1 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
1.1 |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.0 |
0.0 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.0 |
0.0 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.1 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 |
0.3 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.0 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.0 |
0.5 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.0 |
GO:2000858 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.0 |
0.2 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.1 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 |
0.1 |
GO:0033504 |
floor plate development(GO:0033504) |
